FDA reviewing reports of liver injury with orlistat

Links shared publicly online about this topic.

  • 1,797
    total visits

FDA reviewing reports of liver injury with orlistat

endocrinetoday.com

The FDA has issued early communication about an ongoing safety review of adverse event reports of liver injury among people taking orlistat.

View full resource at endocrinetoday.com

Tags: Liver, Obesity Medication, FDA, Xenical

  • Share

Most Recently Shared on August 25, 2009 at 9:02 pm By:

EndocrineToday Endocrine Today

#FDA reviewing reports of liver injury with #orlistat. Read about the early communication review here @ http://ow.ly/ljAu

3 years ago...

FDA: Rare Cases Of Liver Injury Reported With Use Of Xenical, Alli

medicalnewstoday.com — “The U.S. Food and Drug Administration advised consumers and health care professionals about potential rare occurrences of severe liver injury in patients taking the weight-loss medication orlistatView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 27, 2010 at 5:20 pm By:

mnt_liver MNT Liver Disease Health News

FDA: Rare Cases Of Liver Injury Reported With Use Of Xenical, Alli http://mnt.to/3DbC #liver #hepatitis

2 years ago...

Xenical and Alli labeling updated to include reports of severe liver injury - MPR

empr.com — “The FDA has notified healthcare professionals and patients that it has approved revised labeling for Xenical (orlistat, from Roche) and Alli (orlistat, from GlaxoSmithKline) to include new safety information about cases of severe liver injury that have been reported rarely with the use of this medication.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 26, 2010 at 6:39 pm By:

eMPR MPR Medical Publisher

MPR News: Xenical and Alli labeling updated to include reports of severe liver injury: The FDA has notified health... http://bit.ly/cOCLAF

2 years ago...

FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury

fda.gov — “FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injuryView full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on May 26, 2010 at 3:22 pm By:

SamanthaHeller Samantha Heller, RD Nutritionist and Dietitian

FDA: Rare Cases of Liver Injury Reported with Use of Xenical, Alli. http://lb.vg/rx61z

2 years ago...

FDA Issues Early Communication About Ongoing Safety Review Of Weight Loss Drug Orlistat

medicalnewstoday.com — “The U.S. Food and Drug Administration announced that it is reviewing adverse event reports of liver injury in patients taking the weight loss drug orlistat, marketed as the prescription drug XenicView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 24, 2010 at 2:30 am By:

mnt_weightloss MNT Weight Loss News Health News

FDA Issues Early Communication About Ongoing Safety Review Of Weight Loss Drug Orlistat: The U.S. Food and Drug .. http://bit.ly/i2t2n

2 years ago...

FDA Alert: Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review

drugs.com — “FDA Alert: Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety ReviewView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 25, 2009 at 10:08 pm By:

drugscom Drugs.com Health Site

FDA Alert - FDA Reviewing Reports of Liver Failure with Weight Loss Drug Orlistat (marketed as Alli and Xenical) - http://bit.ly/3E8nyv

3 years ago...

Medical News: Reports of Liver Injury Prompt FDA Review of Diet Drug - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA said it has received 32 reports of serious liver injury -- including six cases of liver failure -- among users of diet drug orlistat, which is sold as a prescription drug under tView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 25, 2009 at 5:50 pm By:

medpagetoday MedPage Today Health News

Diet drug Orlistat (aka Xenical or Alli) is suspected in 32 liver damage cases, most occurring outside the U.S. http://bit.ly/FsLhG

3 years ago...

FDA warns of hepatotoxicity risk with Xenical and Alli (orlistat) - MPR

empr.com — “The FDA has notified healthcare professionals and consumers that it is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat, which is marketed in the U.S. as Xenical (from Roche) and Alli (from GlaxoSmithKline).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on August 25, 2009 at 3:12 pm By:

eMPR MPR Medical Publisher

MPR News: FDA warns of hepatotoxicity risk with Xenical and Alli (orlistat): The FDA has notified healt.. http://bit.ly/BdTnB

3 years ago...

Advertisement